These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32107283)

  • 1. Genetic Profile and Functional Proteomics of Anal Squamous Cell Carcinoma: Proposal for a Molecular Classification.
    Trilla-Fuertes L; Ghanem I; Gámez-Pozo A; Maurel J; G-Pastrián L; Mendiola M; Peña C; López-Vacas R; Prado-Vázquez G; López-Camacho E; Zapater-Moros A; Heredia V; Cuatrecasas M; García-Alfonso P; Capdevila J; Conill C; García-Carbonero R; Ramos-Ruiz R; Fortes C; Llorens C; Nanni P; Fresno Vara JÁ; Feliu J
    Mol Cell Proteomics; 2020 Apr; 19(4):690-700. PubMed ID: 32107283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic signatures reveal a dualistic and clinically relevant classification of anal canal carcinoma.
    Herfs M; Longuespée R; Quick CM; Roncarati P; Suarez-Carmona M; Hubert P; Lebeau A; Bruyere D; Mazzucchelli G; Smargiasso N; Baiwir D; Lai K; Dunn A; Obregon F; Yang EJ; Pauw E; Crum CP; Delvenne P
    J Pathol; 2017 Mar; 241(4):522-533. PubMed ID: 27976366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of CYP2D6 copy number variants as prognostic biomarker in localized anal squamous cell carcinoma.
    Trilla-Fuertes L; Gámez-Pozo A; Nogué M; Busquier I; Arias F; López-Campos F; Fernández-Montes A; Ruiz A; Velázquez C; Martín-Bravo C; Pérez-Ruiz E; Asensio E; Hernández-Yagüe X; Rodrigues A; Ghanem I; López-Vacas R; Hafez A; Arias P; Dapía I; Solís M; Dittmann A; Ramos R; Llorens C; Maurel J; Campos-Barros Á; Fresno Vara JÁ; Feliu J
    Cancer; 2023 Aug; 129(16):2581-2592. PubMed ID: 37096763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal Canal.
    Morris V; Rao X; Pickering C; Foo WC; Rashid A; Eterovic K; Kim T; Chen K; Wang J; Shaw K; Eng C
    Mol Cancer Res; 2017 Nov; 15(11):1542-1550. PubMed ID: 28784613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas.
    Van Damme N; Deron P; Van Roy N; Demetter P; Bols A; Van Dorpe J; Baert F; Van Laethem JL; Speleman F; Pauwels P; Peeters M
    BMC Cancer; 2010 May; 10():189. PubMed ID: 20459770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular biology of anal squamous cell carcinoma: implications for future research and clinical intervention.
    Bernardi MP; Ngan SY; Michael M; Lynch AC; Heriot AG; Ramsay RG; Phillips WA
    Lancet Oncol; 2015 Dec; 16(16):e611-21. PubMed ID: 26678214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-infiltrating CD8(+) T lymphocytes associated with clinical outcome in anal squamous cell carcinoma.
    Hu WH; Miyai K; Cajas-Monson LC; Luo L; Liu L; Ramamoorthy SL
    J Surg Oncol; 2015 Sep; 112(4):421-6. PubMed ID: 26287957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes.
    Chung JH; Sanford E; Johnson A; Klempner SJ; Schrock AB; Palma NA; Erlich RL; Frampton GM; Chalmers ZR; Vergilio J; Rubinson DA; Sun JX; Chmielecki J; Yelensky R; Suh JH; Lipson D; George TJ; Elvin JA; Stephens PJ; Miller VA; Ross JS; Ali SM
    Ann Oncol; 2016 Jul; 27(7):1336-41. PubMed ID: 27052656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Description of the genetic variants identified in a cohort of patients diagnosed with localized anal squamous cell carcinoma and treated with panitumumab.
    Trilla-Fuertes L; Gámez-Pozo A; Maurel J; Garcia-Carbonero R; Capdevila J; G-Pastrián L; Mendiola M; Peña C; López-Vacas R; Cuatrecasas M; García-Alfonso P; Ramos-Ruiz R; Llorens C; Ghanem I; Conill C; Heredia-Soto V; Campos-Barros Á; Fresno Vara JÁ; Feliu J
    Sci Rep; 2021 Apr; 11(1):7402. PubMed ID: 33795829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Squamous cell carcinoma antigen: a potentially useful prognostic marker in squamous cell carcinoma of the anal canal and margin.
    Williams M; Swampillai A; Osborne M; Mawdsley S; Hughes R; Harrison M; Harvey R; Glynne-Jones R;
    Cancer; 2013 Jul; 119(13):2391-8. PubMed ID: 23576077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and genomic characterisation of a panel of human anal cancer cell lines.
    Guerra GR; Kong JC; Millen RM; Read M; Liu DS; Roth S; Sampurno S; Sia J; Bernardi MP; Chittleborough TJ; Behrenbruch CC; Teh J; Xu H; Haynes NM; Yu J; Lupat R; Hawkes D; Di Costanzo N; Tothill RW; Mitchell C; Ngan SY; Heriot AG; Ramsay RG; Phillips WA
    Cell Death Dis; 2021 Oct; 12(11):959. PubMed ID: 34663790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour-infiltrating lymphocyte scores effectively stratify outcomes over and above p16 post chemo-radiotherapy in anal cancer.
    Gilbert DC; Serup-Hansen E; Linnemann D; Høgdall E; Bailey C; Summers J; Havsteen H; Thomas GJ
    Br J Cancer; 2016 Jan; 114(2):134-7. PubMed ID: 26730577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel candidate genes may be possible predisposing factors revealed by whole exome sequencing in familial esophageal squamous cell carcinoma.
    Forouzanfar N; Baranova A; Milanizadeh S; Heravi-Moussavi A; Jebelli A; Abbaszadegan MR
    Tumour Biol; 2017 May; 39(5):1010428317699115. PubMed ID: 28459198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of HIV Status With Local Immune Response to Anal Squamous Cell Carcinoma: Implications for Immunotherapy.
    Yanik EL; Kaunitz GJ; Cottrell TR; Succaria F; McMiller TL; Ascierto ML; Esandrio J; Xu H; Ogurtsova A; Cornish T; Lipson EJ; Topalian SL; Engels EA; Taube JM
    JAMA Oncol; 2017 Jul; 3(7):974-978. PubMed ID: 28334399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-exome sequencing identified mutational profiles of squamous cell carcinomas of anus.
    Shin S; Park HC; Kim MS; Han MR; Lee SH; Jung SH; Lee SH; Chung YJ
    Hum Pathol; 2018 Oct; 80():1-10. PubMed ID: 29555573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squamous-cell carcinoma of the anus with high intratumoral lymphocytosis and its clinical implications.
    Rubio CA; Nilsson PJ
    Anticancer Res; 2008; 28(4C):2469-72. PubMed ID: 18751436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-infiltrating cytotoxic T cells but not regulatory T cells predict outcome in anal squamous cell carcinoma.
    Grabenbauer GG; Lahmer G; Distel L; Niedobitek G
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3355-60. PubMed ID: 16740757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p16INK4A, p53, EGFR expression and KRAS mutation status in squamous cell cancers of the anus: correlation with outcomes following chemo-radiotherapy.
    Gilbert DC; Williams A; Allan K; Stokoe J; Jackson T; Linsdall S; Bailey CM; Summers J
    Radiother Oncol; 2013 Oct; 109(1):146-51. PubMed ID: 24021343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low mutation percentage of KRAS and BRAF genes in Brazilian anal tumors.
    Bidinotto LT; Véo CA; Loaiza EA; De França AP; Lorenzi AT; Rosa LA; De Oliveira CM; Levi JE; Scapulatempo-Neto C; Longatto-Filho A; Reis RM
    Mol Med Rep; 2016 Oct; 14(4):3791-7. PubMed ID: 27573925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic Features Associated With Human Papillomavirus/p16 in Patients With Metastatic Squamous Cell Carcinoma of the Anal Canal.
    Morris VK; Rashid A; Rodriguez-Bigas M; Das P; Chang G; Ohinata A; Rogers J; Crane C; Wolff RA; Eng C
    Oncologist; 2015 Nov; 20(11):1247-52. PubMed ID: 26382740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.